CJC-1295 + Ipamorelin · research guide · research use
CJC-1295 + Ipamorelin, and why the pair ships in one vial.
CJC-1295 and Ipamorelin get searched together because the literature studies them together: a GHRH-receptor analog paired with a selective GHS-receptor agonist, acting on complementary points of the same secretagogue pathway. This guide covers how each works in research framing, why Titan pre-blends them into one 5mg/5mg lyophilized vial, and how to read the documentation before ordering.
CJC-1295 — the GHRH analog
CJC-1295 (no DAC) is a synthetic growth-hormone-releasing-hormone analog that acts at the GHRH receptor. It appears in research literature on the GH/IGF-1 axis as a pathway-stimulus tool, studied for how GHRH-receptor activity shapes secretagogue research models.
Ipamorelin — the GHS-receptor agonist
Ipamorelin is a selective growth-hormone-secretagogue (GHS / ghrelin) receptor agonist. In the literature it is studied for receptor selectivity, and it is frequently cited alongside CJC-1295 because the two act on complementary receptors in the same research pathway.
Why they are pre-blended
The CJC-1295 + Ipamorelin pairing is one of the most-cited secretagogue combinations in the literature, so Titan supplies it as a single pre-blended 5mg/5mg lyophilized vial — one reconstitution, one lot release sheet, both compounds at an HPLC ≥99% main-peak purity target.
What Titan exposes before checkout
One vial, two compounds, one paper trail.
The blend is built around the questions secretagogue researchers ask: which receptors, what is in the vial, how is purity measured, and how is it reconstituted. Everything is documentation-first — and the research-use boundary is stated on every surface.
- Format
- Pre-blended single lyophilized vial
- Content
- CJC-1295 (no DAC) 5mg + Ipamorelin 5mg
- Receptors
- GHRH receptor (CJC-1295) + GHS/ghrelin receptor (Ipamorelin)
- Reconstitution
- Bacteriostatic water to a researcher-set concentration
- Purity target
- HPLC ≥99% main-peak, identity confirmation by MS
- COA path
- Lot-matched release sheet tied to the vial code
Order the CJC-1295 + Ipamorelin blend.
Titan stocks the pre-blended 5mg/5mg vial with a lot-matched release sheet, an HPLC ≥99% main-peak purity target, and crypto checkout. Open the product page for current pricing and documentation.